Download free PDF

Oncology Information System Market Size & Share 2023 to 2032

Market Size by Products & Services (Software {Patient Information Systems, Treatment Planning System}, Services), Application (Medical Oncology), End Use (Hospitals & Diagnostic Imaging Centers), Global Forecast.

Report ID: GMI6110
   |
Published Date: June 2023
 | 
Report Format: PDF

Download Free PDF

Oncology Information System Market Size

Oncology Information System Market size accounted for USD 3.1 billion in 2022 and is estimated to grow at 7.9% to reach USD 6.6 billion by 2032. Government initiatives aimed at improving cancer care infrastructure, increasing usage of digital health technologies, and enhancing patient outcomes through proper data management will contribute to the market growth.

Oncology Information System Market Key Takeaways

Market Size & Growth

  • 2022 Market Size: USD 3.1 Billion
  • 2032 Forecast Market Size: USD 6.6 Billion
  • CAGR (2023–2032): 7.9%

Key Market Drivers

  • Increasing prevalence of cancer.
  • Growing government initiatives for cancer.
  • Technological advancements and growing emphasis on precision medicine.

Challenges

  • Dearth of skilled professionals.
  • Data security and privacy concerns.

Also, funding and grants provided by government bodies and research organizations is expected to fuel the advancements in OIS technology. For instance, as per the National Cancer Institute (NCI) report, the Consolidated Appropriations Act, 2023, allocated USD 7.3 billion to National Cancer Institute (NCI) including USD 216 million for the NCI component of the Cancer Moonshot.
 

Oncology information systems (OIS) refer to specialized software solutions designed to streamline and optimize the management of patient information, treatment plans, and clinical workflows in the field of oncology.
 

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the oncology information system (OIS) market. The healthcare sector, including oncology departments and cancer treatment centers, faced numerous challenges during the pandemic, leading to disruptions in OIS implementations and utilization. The diversion of resources and healthcare professionals to address the immediate requirements of COVID-19 patients resulted in delays in the adoption of oncology information system, thereby hampered the market growth. Additionally, restrictions on non-essential medical procedures and reduced patient visits had negatively impacted the market expansion.
 

Oncology Information System Market

Oncology Information System Market Trends

The increasing prevalence of cancer worldwide is anticipated to boost the market progression. For instance, according to the Cancer Research UK report, in 2020, an estimated 18 million new cancer cases were diagnosed, and 10 million cancer deaths occurred across the globe. As the number of cancer cases continues to rise, there is a growing requirement for efficient and advanced systems to manage patient data. OIS solutions play a vital role in effectively organizing and analysing large volumes of patient data, enabling healthcare providers to develop personalized treatment plans and optimize care delivery.
 

Oncology Information System Market Restraint

The dearth of skilled professionals may hamper the market share. The successful implementation and utilization of oncology information system require experienced and trained professionals who can effectively navigate the system, manage patient data, and ensure accurate treatment planning. Therefore, the demand for skilled OIS professionals often outweighs the available supply, thereby leading to a shortage of qualified professionals. Thus, the lack of skilled professionals may hamper the seamless integration and utilization of OIS in healthcare facilities.
 

Oncology Information System Market Analysis

Oncology Information System Market, By Product & Services,

By product & services, the oncology information system market is classified into software and services. The software segment accounted for 83.2% of the market share in 2022 and is projected to witness considerable growth over the analysis timeframe. The integration of artificial intelligence (AI) and machine learning (ML) algorithms in OIS software brings additional benefits to it, including improved clinical decision-making and predictive analytics. This will enable healthcare providers to enhance the efficiency and accuracy of cancer care delivery, thereby fostering the market trends. Additionally, growing adoption of software in healthcare facilities such as hospitals and cancer care centers among others will contribute to the market growth.
 

Oncology Information System Market Revenue Share, By Application

Based on application, the oncology information system market is segmented into medical oncology, radiation oncology, and surgical oncology. The radiation oncology segment is expected to register around USD 1.9 billion by 2032. Increasing number of radiosurgeries coupled with growing adoption of oncology information system specifically tailored for radiation oncology is expected to supplement the market expansion. Furthermore, OIS solutions for radiation oncology enable precise and efficient treatment planning, enhance accuracy in radiation dose delivery, and facilitate treatment monitoring and documentation.
 

Based on end-use, the market is segmented into hospitals & diagnostic imaging centers, ablation care centers and cancer care centers, and research facilities. The hospitals & diagnostic imaging centers segment is projected to witness lucrative growth of 7.3% over the analysis timeframe. Hospitals and diagnostic imaging centers are key healthcare providers involved in cancer diagnosis, treatment, and follow-up care. Thus, the increasing adoption of oncology information systems in hospitals and diagnostic imaging centers will accelerate the market trends. Also, growing emphasis on precision medicine coupled with large patient population preferring hospitals for treatment will further augment the market size.
 

North America Oncology Information System Market,

North America oncology information system market accounted for 42.3% business share in 2022 and is anticipated to grow at considerable growth rate during the forecast timeframe. The presence of a strong healthcare IT ecosystem, including electronic health records (EHR) systems is expected to spur the regional market demand. Also, favorable government initiatives coupled with the presence of a well-established research and development infrastructure will contribute to regional growth. Moreover, the increasing advancements in technology along with the presence of key market players in the region will further stimulate market progression.
 

Oncology Information System Market Share

Major market players operating in the oncology information system market include:

  • Elekta
  • Accuray Inc
  • Varian Medical Systems
  • RaySearch Laboratories,
  • Oracle Corporation

These industry players majorly adopt various strategies including collaborations, acquisitions, mergers, and partnerships to create a global footprint and sustain market competition.
 

Oncology Information System Industry News:

  • In May 2022, RaySearch Laboratories AB collaborated with GE Healthcare, a leading global medical technology, diagnostics, and digital solutions company, to develop a new radiation therapy simulation and treatment planning workflow solution. This strategy helped the company to expand its product portfolio and customer base.
     
  • In June 2021, Elekta and Royal Philips extended their collaboration to advance comprehensive and personalized cancer care through precision oncology solutions. This strategy helped the company to expand and grow.
     

The oncology information system market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032, for the following segments:

By Products & Services

  • Software
    • Treatment Planning Systems
    • Patient Information Systems
  • Services

Application

  • Medical Oncology
  • Radiation Oncology
  • Surgical Oncology

End-use

  • Hospitals & Diagnostic Imaging Centers
  • Ablation Care Centers and Cancer Care Centers
  • Research Facilities

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • Rest of Middle East & Africa

 

Authors:  Monali Tayade, Jignesh Rawal

Research methodology, data sources & validation process

This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.

Our 6-step research process

  1. 1. Research design & analyst oversight

    At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.

    Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.

  2. 2. Primary research

    Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.

  3. 3. Data mining & market analysis

    Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.

  4. 4. Market sizing

    Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.

  5. 5. Forecast model & key assumptions

    Every forecast includes explicit documentation of:

    • ✓ Key growth drivers and their assumed impact

    • ✓ Restraining factors and mitigation scenarios

    • ✓ Regulatory assumptions and policy change risk

    • ✓ Technology adoption curve parameter

    • ✓ Macroeconomic assumptions (GDP growth, inflation, currency)

    • ✓ Competitive dynamics and market entry/exit expectations

  6. 6. Validation & quality assurance

    The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.

    Our triple-layer validation process ensures maximum data reliability:

    • ✓ Statistical Validation

    • ✓ Expert Validation

    • ✓ Market Reality Check

Trust & credibility

10+
Years in Service
Consistent delivery since establishment
A+
BBB Accreditation
Professional standards & satisfaction
ISO
Certified Quality
ISO 9001-2015 Certified Company
150+
Research Analysts
Across 10+ industry verticals
95%
Client Retention
5-year relationship value

Verified data sources

  • Trade publications

    Security & defense sector journals and trade press

  • Industry databases

    Proprietary and third-party market databases

  • Regulatory filings

    Government procurement records and policy documents

  • Academic research

    University studies and specialist institution reports

  • Company reports

    Annual reports, investor presentations, and filings

  • Expert interviews

    C-suite, procurement leads, and technical specialists

  • GMI archive

    13,000+ published studies across 30+ industry verticals

  • Trade data

    Import/export volumes, HS codes, and customs records

Parameters studied & evaluated

Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →

Frequently Asked Question(FAQ) :
What is the size of the oncology information system market?
Oncology information system industry size reached USD 3.1 billion in 2022 and will record USD 6.6 billion in revenue by end of 2032 due to the surge in usage of digital health technologies worldwide.
Why is the demand for radiation oncology information systems increasing?
Radiation oncology information system industry share is estimated to reach USD 1.9 billion by end of 2032 due to the rising number of radiosurgeries.
What is the oncology information system industry worth in North America?
North America held 42.3% market share of the oncology information system market share in 2022 and is anticipated to expand through 2032 owing to the strong presence of well-established healthcare IT ecosystem in the region.
Who are the key oncology information system industry players?
Some of the major oncology information system companies include Elekta, Accuray Inc., Varian Medical Systems, RaySearch Laboratories, and Oracle Corporation, among others
Oncology Information System Market Scope
  • Oncology Information System Market Size

  • Oncology Information System Market Trends

  • Oncology Information System Market Analysis

  • Oncology Information System Market Share

Authors:  Monali Tayade, Jignesh Rawal
Explore Our Licensing Options:

Starting at: $2,450

Premium Report Details:

Base Year: 2022

Companies Profiled: 10

Tables & Figures: 259

Countries Covered: 19

Pages: 220

Download Free PDF

We use cookies to enhance user experience. (Privacy Policy)